This topic contains a solution. Click here to go to the answer

Author Question: Research on the impact of matching the client's race and ethnicity with the therapist's indicates ... (Read 29 times)

leilurhhh

  • Hero Member
  • *****
  • Posts: 560
Research on the impact of matching the client's race and ethnicity with the
  therapist's indicates that
 
  a. racial matching is crucial to success, but ethnic matching is less conclusive.
  b. there is no solid evidence that outcomes are diminished when client and therapist are not matched.
  c. while clients do not care whether there is a match, outcomes are influenced by a lack of matching.
  d. racial matching is crucial to success, but matching on the client's primary language is not.

Question 2

The most common chromosomal abnormality seen in Down syndrome is the
  __________ of chromosome 21.
 
  Fill in the blanks with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nital

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

b. There is no solid evidence that outcomes are diminished when client and therapist are not matched.

Answer to Question 2

trisomy




leilurhhh

  • Member
  • Posts: 560
Reply 2 on: Jun 22, 2018
Wow, this really help


xoxo123

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The term bacteria was devised in the 19th century by German biologist Ferdinand Cohn. He based it on the Greek word "bakterion" meaning a small rod or staff. Cohn is considered to be the father of modern bacteriology.

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library